Equities Analysts Offer Predictions for TG Therapeutics Inc’s FY2018 Earnings (TGTX)
TG Therapeutics Inc (NASDAQ:TGTX) – SunTrust Banks decreased their FY2018 earnings per share estimates for TG Therapeutics in a report released on Wednesday, November 28th. SunTrust Banks analyst P. Lawson now expects that the biopharmaceutical company will post earnings of ($2.06) per share for the year, down from their prior estimate of ($2.02). SunTrust Banks also issued estimates for TG Therapeutics’ FY2019 earnings at ($2.06) EPS, FY2020 earnings at ($2.66) EPS and FY2021 earnings at ($1.91) EPS.